Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1988 | 03-1988 | 12-1987 | |
| Cash Flows From Operating Activities | |||
| Net Income | -1,796 | -1,796 | -1,796 |
| Depreciation Amortization | 165 | 165 | 165 |
| Other Working Capital | 125 | 125 | 125 |
| Operating Cash Flow | $-1,506 | $-1,506 | $-1,506 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -204 | -204 | -204 |
| Other Investing Activity | 956 | 956 | 956 |
| Investing Cash Flow | $752 | $752 | $752 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | -17 | -17 | -17 |
| Financing Cash Flow | $-17 | $-17 | $-17 |
| Beginning Cash Position | 1,403 | 1,403 | 1,403 |
| End Cash Position | 631 | 631 | 631 |
| Net Cash Flow | $-772 | $-772 | $-772 |
| Free Cash Flow | |||
| Operating Cash Flow | -1,506 | -1,506 | -1,506 |
| Free Cash Flow | -1,506 | -1,506 | -1,506 |